MedPath

APHAIA PHARMA US, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:2
Completed:3

Trial Phases

2 Phases

Phase 1:3
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (50.0%)
Phase 2
3 (50.0%)

A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

Phase 2
Not yet recruiting
Conditions
Obese With Comorbidities
Obese Patients (BMI ≥ 30 kg/m²)
Interventions
Drug: APHD-002
Drug: APHP-012
Drug: APHP-002
First Posted Date
2025-06-06
Last Posted Date
2025-06-06
Lead Sponsor
Aphaia Pharma US LLC
Target Recruit Count
102
Registration Number
NCT07008456
Locations
🇬🇪

LTD "Israeli-Georgian Medical Research Clinic Healthycore", Tbilisi, Georgia

🇬🇪

LTD "New Hospitals", Tbilisi, Georgia

🇬🇪

LTD "Acad. G. Chapidze Emergency Cardiology Center", Tbilisi, Georgia

and more 3 locations

A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test

Phase 2
Completed
Conditions
PreDiabetes
Glucose Tolerance Impaired
Interventions
Drug: APH-012P
First Posted Date
2023-04-07
Last Posted Date
2024-10-16
Lead Sponsor
Aphaia Pharma US LLC
Target Recruit Count
31
Registration Number
NCT05803772
Locations
🇸🇰

Cell-B s.r.o., Levice, Slovenska, Slovakia

🇸🇰

ALIAN, s.r.o., Bardejov, Slovakia

🇸🇰

MEDISPEKTRUM s.r.o., Bratislava, Slovakia

Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

Phase 1
Completed
Conditions
Obese
Interventions
Drug: Glucose 12 g coated beads (60% w/w)
Drug: Glucose 8 g coated beads (47% w/w)
Drug: Glucose 16 g coated beads (47% w/w)
Drug: Glucose 12 g coated beads (47% w/w)
Drug: Glucose 12 g uncoated beads
First Posted Date
2023-02-21
Last Posted Date
2023-02-21
Lead Sponsor
Aphaia Pharma US LLC
Target Recruit Count
20
Registration Number
NCT05737927
Locations
🇷🇴

NovaClin Medical Research Center S.R.L, Timisoara, Romania

Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

Phase 1
Completed
Conditions
Obesity
Metabolic Syndrome
Interventions
Drug: coated beads glucose (8 g) and caffeine anhydrous
Drug: uncoated beads glucose (8 g) and caffeine anhydrous
Drug: coated beads glucose (8 g)
First Posted Date
2023-02-06
Last Posted Date
2023-02-06
Lead Sponsor
Aphaia Pharma US LLC
Target Recruit Count
20
Registration Number
NCT05713773
Locations
🇷🇴

Nova-Clin Medical Research Center S.R.L.,, Timisoara, Romania

A Study of Distal Jejunal-release Dextrose in Obese Participants

Phase 2
Active, not recruiting
Conditions
Obese
Interventions
Drug: APHD-012P
First Posted Date
2022-05-23
Last Posted Date
2024-10-16
Lead Sponsor
Aphaia Pharma US LLC
Target Recruit Count
150
Registration Number
NCT05385978
Locations
🇬🇪

LTD "Israeli-Georgian Medical Research Clinic Healthycore", Tbilisi, Georgia

🇬🇪

LTD "Acad. G. Chapidze Emergency Cardiology Center", Tbilisi, Georgia

🇬🇪

LTD "Diacor", Tbilisi, Georgia

and more 6 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath